These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7333095)

  • 1. Decreased 3H-imipramine binding in depressed males and females.
    Asarch KB; Shih JC; Kulscàr A
    Commun Psychopharmacol; 1980; 4(5):425-32. PubMed ID: 7333095
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients.
    Georgotas A; Schweitzer J; McCue RE; Armour M; Friedhoff AJ
    Life Sci; 1987 Jun; 40(22):2137-43. PubMed ID: 3035303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-imipramine and 3H-desipramine binding sites in depression.
    Langer SZ; Raisman R; Sechter D; Gay C; Loo H; Zarifian E
    Adv Biochem Psychopharmacol; 1984; 39():113-25. PubMed ID: 6380221
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".
    Paul SM; Rehavi M; Skolnick P; Ballenger JC; Goodwin FK
    Arch Gen Psychiatry; 1981 Dec; 38(12):1315-7. PubMed ID: 7316676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 8. 3H-imipramine platelet binding sites in unipolar depression.
    Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
    Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine binding in subpopulations of normal human blood platelets.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1984 Feb; 19(2):257-62. PubMed ID: 6713038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tranylcypromine stereoisomers on depressive syndromes.
    Rüther E; Jungkunz G; Greil W; Zimmer R
    Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
    [No Abstract]   [Full Text] [Related]  

  • 11. Seasonal variation in platelet 3H-imipramine binding in man.
    Mendlewicz J
    Psychiatry Res; 1984 Jun; 12(2):179-81. PubMed ID: 6591223
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
    Mellerup ET; Plenge P
    Eur J Pharmacol; 1986 Jul; 126(1-2):155-8. PubMed ID: 3758160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggression and suicide attempts: preliminary data.
    Marazziti D; Conti L
    Eur Neuropsychopharmacol; 1991 May; 1(2):169-72. PubMed ID: 1821706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid changes in 3H-imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients.
    Gronier B; Jeanningros R
    Fundam Clin Pharmacol; 1992; 6(2):89-95. PubMed ID: 1607147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
    Commun Psychopharmacol; 1980; 4(5):441-5. PubMed ID: 7333096
    [No Abstract]   [Full Text] [Related]  

  • 19. Onset of winter depression earlier than generally thought?
    Dilsaver SC
    J Clin Psychiatry; 1990 Jun; 51(6):258. PubMed ID: 2347865
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of melancholia with tranylcypromine.
    McGrath PJ; Quitkin FM; Harrison W; Stewart JW
    Am J Psychiatry; 1984 Feb; 141(2):288-9. PubMed ID: 6691499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.